Akso Health Group current report, Q4 FY2018

Business Context and Reporting Period

This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of December 2018. The report was signed on December 3, 2018, by Zhang Qisen (Johnson), Chief Financial Officer. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing includes a press release as Exhibit 99.1.

Key Financial Metrics

The provided text contains only the cover page and exhibit index of the Form 6-K. It does not include the content of the press release or any financial statements. Consequently, the filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics.

Material Changes

No material changes versus the prior comparable period can be identified from the provided text, as no financial data or operational updates are included in the excerpt.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or descriptions of unusual items. These details would typically be found in the attached press release (Exhibit 99.1), which is not included in the input content.

Important Facts for Investor Verification

  • The filing is a Form 6-K for Hexindai Inc. dated December 3, 2018.
  • The document references a press release (Exhibit 99.1) that is not included in the provided text.
  • No financial figures or operational data are present in the cover page excerpt.
  • Investors must locate the full text of Exhibit 99.1 to verify any material announcements or financial results.